In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a clinical study to confirm the safety of long-term administration of a therapeutic drug.
Clinical Trials Must Be More Equitable, Here’s How
Gav Martell, VP of Business Development & Co-founder at Yonalink The Need to Address Accessibility Gaps Clinical trials are a driving force of medical innovation.
July 31, 2024